AKERO THERAPEUTICS INC (AKRO)
US00973Y1082 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to AKRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 46.69. This target is 51.11% above the current price.
AKRO was analyzed by 17 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about AKRO.
In the previous month the buy percentage consensus was at a similar level.
AKRO was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-12 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-11 | Wolfe Research | Initiate | Outperform |
| 2024-06-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-05-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | B of A Securities | Reiterate | Neutral |
| 2024-03-05 | UBS | Maintains | Buy -> Buy |
| 2024-03-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-12 | UBS | Maintains | Buy -> Buy |
| 2023-10-11 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-10-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-04 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-09-19 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-09-13 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2023-09-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-28 | UBS | Initiate | Buy |
| 2023-06-12 | Morgan Stanley | Maintains | Overweight |
| 2023-06-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-05-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-21 | Canaccord Genuity | Maintains | Buy |
| 2023-03-20 | HC Wainwright & Co. | Reiterate | Buy |